- Home
- CAG
CAG
ConAgra Brands Inc.
as 06-02-2025 9:47am EST
| Founded: | 1919 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $27.60 | AVG Volume (30 days): | 7.1M |
| Analyst Decision: | Hold | Number of Analysts: | 10 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.68 | EPS Growth: | -65.85 |
| 52 Week Low/High: | $21.98 - $33.24 | Next Earning Date: | 07-10-2025 |
| Revenue: | $11,736,900,000 | Revenue Growth: | -3.15% |
| Revenue Growth (this year): | -1.92% | Revenue Growth (next year): | 1.07% |
Latest ConAgra Brands Inc. News
CAG Breaking Stock News: Dive into CAG Ticker-Specific Updates for Smart Investing
GOBankingRates
a day ago
7 Summer Side Hustles That Can Pay $1,000 a Week or More
Yahoo Finance Video
a day ago
Will Tesla have to play catch up to Waymo's robotaxis?
Yahoo Finance
a day ago
Why Scott Bessent wants to make it easier for banks to own Treasurys
The Guardian
a day ago
When are people too old to do their jobs?
GlobeNewswire
a day ago
EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry
CNW Group
a day ago
Statement by Minister Guilbeault on Portuguese Heritage Month
PR Newswire
a day ago
Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population
GlobeNewswire
a day ago
Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
Compare CAG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CAG ConAgra Brands Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.